Journal Home
Search for

Volume 20, Issue 8, Pages 584-591 (August 2010)


View previous. 5 of 13 View next.

Does Chocolate Intake During Pregnancy Reduce the Risks of Preeclampsia and Gestational Hypertension?

Audrey F. Saftlas, PhD, MPHa, Elizabeth W. Triche, PhDb, Hind Beydoun, PhD, MPHa, Michael B. Bracken, PhD, MPHbCorresponding Author Informationemail address

Received 8 March 2010; accepted 10 May 2010.

Purpose

Chocolate consumption is associated with favorable levels of blood pressure and other cardiovascular disease risk markers. We analyzed a prospective cohort study to determine whether regular chocolate intake during pregnancy is associated with reduced risks of preeclampsia and gestational hypertension (GH).

Methods

Subjects were recruited from 13 prenatal care practices in Connecticut (1988−1991). In-person interviews were administered at <16 weeks' gestation to ascertain risk factors for adverse pregnancy outcomes. Hospital delivery and prenatal records were abstracted to classify preeclampsia (n = 58), GH (n = 158), and normotensive pregnancies (n = 2351). Chocolate consumption (servings/week) during the first and third trimesters was ascertained at initial interview and immediately postpartum, respectively. Consumers of less than 1 serving/week comprised the referent group. Adjusted odds ratios (aORs) were estimated by the use of logistic regression.

Results

Chocolate intake was more frequent among normotensive (80.7%) than preeclamptic (62.5%) or GH women (75.8%), and associated with reduced odds of preeclampsia (first trimester: aOR, 0.55; 95% confidence interval [95% CI], 0.32−0.95; third trimester: aOR, 0.56; 95% CI, 0.32−0.97). Only first trimester intake was associated with reduced odds of GH (aOR,0.65; 95% CI, 0.45−0.87).

Conclusions

These findings provide additional evidence of the benefits of chocolate. Prospective studies are needed to confirm and delineate protective effects of chocolate intake on risk of preeclampsia.

a Department of Epidemiology, University of Iowa College of Public Health, Iowa City

b Center for Perinatal, Pediatric, and Environmental Epidemiology, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT

Corresponding Author InformationAddress correspondence to: Michael B. Bracken, PhD, MPH, Center for Perinatal Pediatric and Environmental Epidemiology, Yale University Schools of Public Health and Medicine, 1 Church Street, 6th Floor, New Haven, CT 06510. Tel.: 203 764-9375; Fax: 203 764-9378.

 Supported by National Institutes of Health Grants HD32579, AI41040 and DA05484.

PII: S1047-2797(10)00121-3

doi:10.1016/j.annepidem.2010.05.010


View previous. 5 of 13 View next.